---
title: Acyclovir
aliases: ['Acyclovir', 'Zovirax']
slug: /drugs/acyclovir
tags: ["antiviral", "herpes", "HSV", "VZV", "shingles", "chickenpox"]
category: "Antivirals"
date: "27-10-2025"
updated: "27-10-2025"
keywords: ["acyclovir", "herpes simplex", "herpes zoster", "varicella zoster", "antiviral"]
sources: ["BNF", "MHRA"]
---

## Indication

- Herpes Simplex Virus (HSV) infections
- herpes zoster (shingles)
- chickenpox (varicella)

---

## Dose

### Paediatric

<Table>
  <TableHeader>
    <TableRow>
      <TableHead>Age Group</TableHead>
      <TableHead>Indication</TableHead>
      <TableHead>Dose</TableHead>
      <TableHead>Notes</TableHead>
    </TableRow>
  </TableHeader>
  <TableBody>
    <TableRow>
      <TableCell>2 to 12 years</TableCell>
      <TableCell>Chickenpox (Varicella)</TableCell>
      <TableCell>20 mg/kg (Oral)</TableCell>
      <TableCell>4 times daily for 5 days. Max 800 mg per dose. Start within 24 hours of rash onset.</TableCell>
    </TableRow>
    <TableRow>
      <TableCell>3 months to 12 years</TableCell>
      <TableCell>Severe HSV/VZV (IV)</TableCell>
      <TableCell>10 to 20 mg/kg (IV)</TableCell>
      <TableCell>Every 8 hours. Dose and duration highly variable, requires specialist guidance.</TableCell>
    </TableRow>
    <TableRow>
      <TableCell>Neonates ($\le$4 weeks)</TableCell>
      <TableCell>Neonatal HSV (IV)</TableCell>
      <TableCell>20 mg/kg (IV)</TableCell>
      <TableCell>Every 8 or 12 hours depending on gestational age. Duration 14-21 days.</TableCell>
    </TableRow>
  </TableBody>
</Table>

### Adults and adolescents â‰¥12 years

<Table>
  <TableHeader>
    <TableRow>
      <TableHead>Indication</TableHead>
      <TableHead>Dose</TableHead>
      <TableHead>Frequency</TableHead>
      <TableHead>Notes</TableHead>
    </TableRow>
  </TableHeader>
  <TableBody>
    <TableRow>
      <TableCell>Genital Herpes (Initial)</TableCell>
      <TableCell>200 mg (Oral)</TableCell>
      <TableCell>5 times daily</TableCell>
      <TableCell>For 5 to 10 days. Initiate at earliest sign.</TableCell>
    </TableRow>
    <TableRow>
      <TableCell>Genital Herpes (Suppression)</TableCell>
      <TableCell>400 mg (Oral)</TableCell>
      <TableCell>Twice daily</TableCell>
      <TableCell>Duration up to 12 months, then review.</TableCell>
    </TableRow>
    <TableRow>
      <TableCell>Herpes Zoster (Shingles)</TableCell>
      <TableCell>800 mg (Oral)</TableCell>
      <TableCell>5 times daily</TableCell>
      <TableCell>For 7 days. Start within 72 hours of rash onset.</TableCell>
    </TableRow>
    <TableRow>
      <TableCell>Severe VZV/HSV (IV)</TableCell>
      <TableCell>5 to 10 mg/kg (IV)</TableCell>
      <TableCell>Every 8 hours</TableCell>
      <TableCell>Dose and duration dependent on site (e.g., Encephalitis: 10 mg/kg q8h for 14-21 days).</TableCell>
    </TableRow>
  </TableBody>
</Table>

---

## Administration

- Take with or without food.

---

## Contraindications

- **Precautionary Use:**
  - Patients with **renal impairment**: Dose must be reduced to prevent drug accumulation and nephrotoxicity.
  - **Elderly patients**: Higher risk of neurotoxicity; monitor renal function closely.
  - Patients receiving other **nephrotoxic drugs** (e.g., ciclosporin, aminoglycosides).
  - Patients with underlying **neurological abnormalities** or significant dehydration.

---

## Adverse Reactions

- **Common**
  - Headache, dizziness.
  - Gastrointestinal disturbances (nausea, vomiting, diarrhoea, abdominal pain).
  - Skin rashes (including photosensitivity).
  - Pruritus.

- **Uncommon/Rare (Systemic)**
  - **Renal Impairment/Crystalluria** (especially with rapid IV infusion or dehydration).
  - **Neurotoxicity** (confusion, hallucinations, agitation, tremors, seizures, coma) - more common in renal impairment or high doses.
  - Elevated liver enzymes (reversible rise in transaminases).
  - Haematological changes (anaemia, neutropenia, thrombocytopenia) - rare.
  - Anaphylaxis.

---

## Pregnancy and Lactation

<Callout type='warning'>
**Pregnancy:**
Large experience suggests aciclovir poses **no increased risk** of foetal malformations.
Use when **clinically necessary** and benefits outweigh potential risks.
IV therapy should be considered for severe or life-threatening maternal infections.

**Lactation:**
Aciclovir is excreted into breast milk; infant exposure is low.
It is generally considered **safe** to breastfeed while taking aciclovir at therapeutic doses.
Monitor the infant for any unusual symptoms.
</Callout>

---
